FDA Inspection 1210563 — Genesis Biologics, Inc.

Genesis Biologics, Inc. — FEI 3008066433

The FDA completed an inspection of Genesis Biologics, Inc. on Jul 21, 2023 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 21, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Irvine, CA (United States)

Citations

IDCFRDescription
1235121 CFR 1271.190(d)(1)Procedures for cleaning, sanitation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.